Best Medical Stocks To Invest In Right Now

Brighthouse Leaps Into the Annuity Future

Life Insurers May Get an FSOC Bill Onto Trump’s Desk

Your Social Security Number Now Looks Like a Time Bomb. It Is

Centene Corp., a Medicaid plan manager that has been doing well in the Affordable Care Act public exchange market, is expanding into New York state.

The St. Louis-based company said Tuesday it will pay $3.75 billion to acquire “substantially all of the assets” of New York State Catholic Health Plan Inc., which does business as Fidelis Care. Fidelis is a nonprofit health coverage provider based in New York.

Fidelis was providing or administering health coverage for 1.6 million people on June 30, and it generated about $4.8 billion in revenue during the first half of the year. The company competes in the Medicaid plan, Children’s Health Insurance Program and individual major medical markets in New York state. 

(Related: New York Health Insurers Ask for 16.6% Boost to ACA Exchange Rates) 

Best Medical Stocks To Invest In Right Now: Eiffage SA (EFGSY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

Best Medical Stocks To Invest In Right Now: (SIOLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    China Life (NYSE:LFC) holds a 44 percent stake in China Guangfa Bank and a 30 percent stake in Sino-Ocean Group (OTCPK:SIOLF). Foresea owns large stakes in Gree Electric Appliances and China Vanke. If they are forced to sell their stakes, the Chinese stock market could see a sudden downturn.

Best Medical Stocks To Invest In Right Now: G&K Services, Inc.(GK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We maintain our positive view toward Cintas, particularly as G&K Services (GK) is likely to bolster Cintas’s growth potential over the next few years. However, after strong appreciation since the G&K announcement last August, we believe that much of the good news is already priced in at 25x/22x our pro-forma FY18/FY19 adjusted EPS estimates. As a result, we rate CTAS Sector Perform and await a better entry point.

  • [By Ben Levisohn]

    Cintas (CTAS) soared to the top of the S&P 500 today after the uniform provider received the go-ahead for its purchase of G&K Services (GK).

Best Medical Stocks To Invest In Right Now: EPR Properties(EPR)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    Net operating cash flow has increased to $64.42 million or 19.61% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of 9.39%.

    The gross profit margin for EPR PROPERTIES is currently very high, coming in at 73.12%. Regardless of EPR’s high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, EPR’s net profit margin of 46.18% significantly outperformed against the industry.

     

  • [By Laurie Kulikowski]

    EPR PROPERTIES has improved earnings per share by 11.8% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, EPR PROPERTIES reported lower earnings of $2.78 versus $3.13 in the prior year. This year, the market expects an improvement in earnings ($2.91 versus $2.78).

     

  • [By Laurie Kulikowski]

    EPR’s revenue growth has slightly outpaced the industry average of 6.1%. Since the same quarter one year prior, revenues slightly increased by 9.7%. This growth in revenue appears to have trickled down to the company’s bottom line, improving the earnings per share.

     

  • [By Laurie Kulikowski]

    EPR’s investment pipeline should drive about 6-7% earnings growth in 2016, and historically the company’s dividend growth has roughly equated to earnings growth. Starting with an above-average 6.5% yield, we find this compelling for income-oriented investors. 

  • [By Laurie Kulikowski]

    We rate EPR PROPERTIES as a Buy with a ratings score of B. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company’s strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. 

Best Medical Stocks To Invest In Right Now: Coeur d’Alene Mines Corporation(CDE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Still, some stocks managed to buck the negative sentiment on Tuesday, and Sears Holdings (NASDAQ:SHLD), Plug Power (NASDAQ:PLUG) and Coeur Mining (NYSE:CDE) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Manikandan Raman]

    Citing bullish outlook on silver prices, Peter Bures of Canaccord Genuity has started coverage of four silver producers: Pan American Silver Corp. (USA) (NASDAQ: PAAS), Coeur Mining Inc (NYSE: CDE), Hecla Mining Company (NYSE: HL), and Endeavour Silver Corp (NYSE: EXK). The brokerage also assumed coverage of Fortuna Silver Mines Inc (NYSE: FSM) with a Buy rating.

  • [By Ben Levisohn]

    Given revised commodity deck forecasts (particularly for Steel and Gold) and improved Balance Sheet health (Steels, Precious and Industrials Metals) we are upgrading our ratings on several stocks in our coverage. We generally favor companies that have already initiated specific self-help, have low-cost assets and are less exposed to China supply and demand dynamics. In Steels, we have increased our rating from Hold to Buy on Nucor (NUE) and from Sell to Hold on US Steel. We have also upgraded Kinross Gold (KGC) to a Hold on valuation…On higher-than-peer valuations, we reiterate Sell-rated Coeur Mining (CDE), Franco-Nevada (FNV), Goldcorp (GG), Teck Resources (TCK) and highly leveraged AK Steel given preference to issue further equity if possible.

  • [By Ben Levisohn]

    Deutsche Bank’s Jorge Beristain and Chris Terry released their earnings preview for the gold miners–including Barrick Gold (ABX), Goldcorp (GG), Franco-Nevada (FNV), and Coeur Mining (CDE)–and conclude that only one gold miner deserves a Buy rating: Newmont Mining (NEM). They explain why:

Best Medical Stocks To Invest In Right Now: Pinnacle West Capital Corporation(PNW)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Iron Mountain has gained 2.6% to $26.55 at 3:05 p.m., making it the fourth-best performer in the S&P 500, ahead of WPX Energy (WPX), which has gained 2.4% to $19.94, Pinnacle West Capital (PNW), which has gained 2.3% to $53.55 and Dominion Resources (D), which has risen 2.1% to $59.85.